Brain Hypoxia clinical trials at UC Davis
1 research study open to eligible people
open to all eligible people
The goal is to see whether topiramate (an anti-epileptic agent) improves the outcome of babies with neonatal hypoxic encephalopathy who are receiving whole body cooling.
Our lead scientists for Brain Hypoxia research studies include Kristin R Hoffman, MD.